Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer
Jennifer S. Ferris(Queen's University Belfast), Victoria Coyle(Queen's University Belfast), Alex J. McIntyre(Queen's University Belfast), Nyree Crawford, Caitriona Holohan(Queen's University Belfast), Margarita Espona‐Fiedler(Umeå University), Mark Wappett(AstraZeneca (United Kingdom)), Daniel B. Longley(Queen's University Belfast), Claudia Hamilton(Queen's University Belfast), Simon S. McDade(Queen's University Belfast), Jamie Z. Roberts(Queen's University Belfast)
Cited by 43
Related Papers
Transcription Factor Activities Enhance Markers of Drug Sensitivity in Cancer
|Cancer Research|2017|235
MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma
|Modern Pathology|2014|174
Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy
|Annals of Oncology|2017|133
Synthetic Prodiginine Obatoclax (GX15‐070) and Related Analogues: Anion Binding, Transmembrane Transport, and Cytotoxicity Properties
|Chemistry - A European Journal|2011|116
Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach
|British Journal of Cancer|2019|116